MELAS syndrome associated with diabetes mellitus and hyperthyroidism: a case report from Taiwan

MELAS syndrome Is a form of mitochondrial myopathy with manifestations of seizure, stroke‐like syndrome, lactic acidosis, ragged red muscle fibres and mitochondrial encephalopathy. The syndrome has been reported in association with a variety of endocrine and metabolic disorders Including diabetes mellitus (DM), hypothalamo‐pituitary hypofunction, hypothalamic growth hormone deficiency and delayed puberty. Mitochondrial DNA (mtDNA) point mutation may be the major pathological defect. However, association of MELAS syndrome with hyperthyroidism has not previously been reported. A case Is reported from Taiwan of a 32‐year‐old woman suffering from MELAS syndrome with associated DM and hyperthyroidism. When the latter was diagnosed In April 1988, the patient underwent subtotal thyroidectomy. There was no family history of thyroid disease. Because of repeated seizures, she had computed tomography (CT) and magnetic resonance Imaging (MRI) of the brain which showed focal, low‐density lesions over the cerebral hemispheres. Both serum and cerebral spinal fluid lactic acid levels were elevated. Mild elevations of serum T4 and T3 and a high titre of TSH receptor antibody were still present. Hyperglycaemla was noted during hospitalization and DM confirmed by oral glucose tolerance test. Muscle biopsy showed ragged red fibres. DNA analysis showed an A‐to‐G transition at the 3243rd nucleotide position of the tRNALeu(uur)gene of the mtDNA from the patient. Quantitative polymerase chain reaction (PCR) and restriction analysis revealed that about 60% of the blood mtDNA was of mutant type. The patient received antithyroid drugs for hyperthyroidism, diet control for DM and anti‐epileptic drugs for seizure.

[1]  R. Sakuta,et al.  Accumulation of mtDNA with a mutation at position 3271 in tRNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function. , 1993, Biochemical and biophysical research communications.

[2]  Y. Goto [MELAS (mitochondrial myopathy, encephalopathy lactic acidosis, and stroke-like episodes): clinical features and mitochondrial DNA mutations]. , 1993, Nihon rinsho. Japanese journal of clinical medicine.

[3]  Y. Wai,et al.  Overlapping syndrome of MERRF and MELAS: molecular and neuroradiological studies , 1993, Acta neurologica Scandinavica.

[4]  S. Love,et al.  Sequencing and quantitative assessment of mutant and wild‐type mitochondrial DNA in paraffin sections from cases of MELAS , 1993, The Journal of pathology.

[5]  K. Gerbitz,et al.  Diabetes mellitus is one of the heterogeneous phenotypic features of a mitochondrial DNA point mutation within the tRNALeu(UUR) gene , 1993, FEBS letters.

[6]  M. Koshiba,et al.  Organ distribution of mutant mitochondrial tRNAleu(UUR) gene in a MELAS patient , 1993, Acta pathologica japonica.

[7]  T. Hanihara,et al.  Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) and diabetes mellitus: molecular genetic analysis and family study , 1993, Journal of the Neurological Sciences.

[8]  D. Pongratz,et al.  Generalized mitochondrial microangiopathy and vascular cytochrome c oxidase deficiency. Occurrence in a case of MELAS syndrome with mitochondrial cardiomyopathy-myopathy and combined complex I/IV deficiency. , 1993, Archives of pathology & laboratory medicine.

[9]  S. Dimauro,et al.  MELAS: An original case and clinical criteria for diagnosis , 1992, Neuromuscular Disorders.

[10]  M. Pembrey,et al.  Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA , 1992, The Lancet.

[11]  R. Sakuta,et al.  Leigh encephalopathy: histologic and biochemical analyses of muscle biopsies. , 1992, Pediatric neurology.

[12]  D. Barnett,et al.  Endocrine dysfunction in Kearns‐Sayre syndrome , 1992, Clinical endocrinology.

[13]  M. Ōsawa,et al.  [Hypothalamic GH Deficiency and gelastic seizures in a 10-year-old girl with MELAS]. , 1991, No to hattatsu = Brain and development.

[14]  I. Kanazawa,et al.  [Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) associated with hypothalamo-pituitary hypofunction--a case report]. , 1991, Rinsho shinkeigaku = Clinical neurology.

[15]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.

[16]  Y. Wada,et al.  Two cases of NADH-coenzyme Q reductase deficiency: relationship to MELAS syndrome. , 1987, The Journal of pediatrics.

[17]  S. Dimauro,et al.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome , 1984, Annals of neurology.